Rigel Pharmaceuticals, Inc.
RIGLNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $924.68M
- P/E (TTM)
- 2.87
- Forward P/E
- 1.42
- Dividend yield
- -
- 52-week range
- $24.95$52.24
- Volume (live)
- -
- Avg. volume (3M)
- 227.31K
Rigel Pharmaceuticals (RIGL) Stock Price & Financial Analysis
Rigel Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $45.68 - $47.58 |
|---|---|
| 52-Week High | $52.24 |
| 52-Week Low | $24.95 |
| Open | $47.58 |
| Volume (last close) | 141.43K |
| Average Volume (3M) | 227.31K |
| Revenue (TTM) | 276.79M |
|---|---|
| Net Income (TTM) | 321.91M |
| Free Cash Flow (TTM) | 79.39M |
| EPS (TTM) | $16.67 |
| Profit Margin | 116.30% |
| Operating Margin | 31.45% |
| Return on Equity (ROE) | 75.67% |
| Debt to Equity | 0.09 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 924.68M |
|---|---|
| Shares Outstanding | 19.57M |
| P/E Ratio (TTM) | 2.87 |
| Forward P/E | 1.42 |
| Price to Sales (P/S) | 3.34 |
| Price to Book (P/B) | 2.17 |
| EV/EBITDA | 9.61 |
| 50-Day MA | $46.08 |
|---|---|
| 200-Day MA | $36.73 |
| 1-Year Change | +69.11% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Rigel Pharmaceuticals at a Glance
As of the Oct 16, 2026 close, Rigel Pharmaceuticals (RIGL) has a market capitalization of $924.68M. The stock trades at 2.9× trailing earnings, 1.4× forward earnings and 3.3× sales. Over the trailing twelve months it earned $321.91M on revenue of $276.79M (a 116.3% profit margin) and generated $79.39M of free cash flow. Revenue grew 3.3% year over year.
As of its latest reported balance sheet, it holds $60.82M in cash and securities against $39.29M of debt, a net cash position of $21.52M.
Rigel Pharmaceuticals does not currently pay a dividend.
The share price is up 69.1% over the past year. At $45.95 (the Oct 16, 2026 close) it sits within its 52-week range of $24.95 to $52.24, above its 200-day moving average of $36.73.
Based on 1 professional analyst rating from the past 90 days, the consensus is Sell.
Frequently Asked Questions About Rigel Pharmaceuticals
What is the current stock price for RIGL?
As of the Oct 16, 2026 close, RIGL stock trades at $45.95. The 52-week range is $24.95–$52.24, with a day range of $45.68–$47.58.
What is the P/E ratio for RIGL?
As of the Oct 16, 2026 close, Rigel Pharmaceuticals's trailing twelve-month (TTM) P/E ratio is 2.9, meaning investors pay $2.9 for every $1 of annual earnings. The forward P/E is 1.4, reflecting analyst expectations for future earnings. Rigel Pharmaceuticals operates in the Healthcare sector.
Does RIGL pay dividends?
Rigel Pharmaceuticals does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for RIGL?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for RIGL is Sell.
What is the market cap of RIGL?
As of the Oct 16, 2026 close, Rigel Pharmaceuticals's market capitalization is $899.2M, classifying it as a small-cap company. Rigel Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.